Brief: Exagen Releases Largest Comparative Utility Study In Lupus Diagnostics Confirming Avise® Lupus Delivers Unparalleled Utility
05/07/2022 13:28
July 5 (Reuters) - Exagen Inc XGN.O :
* EXAGEN RELEASES LARGEST COMPARATIVE UTILITY STUDY IN LUPUS
DIAGNOSTICS CONFIRMING AVISE® LUPUS DELIVERS UNPARALLELED
UTILITY
Source text for Eikon: ID:nGNX9GRXvF
Further company coverage: XGN.O
Recent news on Exagen
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Exagen Inc. reports results for the quarter ended June 30 - Earnings Summary
Exagen Q2 revenue beats on test volume growth; raises 2026 outlook
Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview
Exagen beats Q1 revenue estimates, reaffirms 2026 guidance